Cargando…

Mutation-Derived Long Noncoding RNA Signature Predicts Survival in Lung Adenocarcinoma

BACKGROUND: Genomic instability is one of the representative features of cancer evolution. Recent research has revealed that long noncoding RNAs (lncRNAs) play a critical role in maintaining genomic instability. Our work proposed a gene signature (GILncSig) based on genomic instability-derived lncRN...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Longjun, Guo, Guangran, Yu, Xiangyang, Wen, Yingsheng, Lin, Yongbin, Zhang, Rusi, Zhao, Dechang, Huang, Zirui, Wang, Gongming, Yan, Yan, Zhang, Xuewen, Chen, Dongtai, Xing, Wei, Wang, Weidong, Zeng, Weian, Zhang, Lanjun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8965709/ https://www.ncbi.nlm.nih.gov/pubmed/35372012 http://dx.doi.org/10.3389/fonc.2022.780631

Ejemplares similares

Development and validation of a prediction model for lung adenocarcinoma based on RNA-binding protein
por: Yang, Longjun, et al.
Publicado: (2021)

Analysis of the tumor immune environment identifies an immune gene set–based prognostic signature in non-small cell lung cancer
por: Guo, Guangran, et al.
Publicado: (2022)

The Independent Prognostic Effect of Lymph Node Dissection on Patients With Stage IA NSCLC With Different T Stages
por: Zhao, Dechang, et al.
Publicado: (2021)

The independent prognostic effect of marital status on non-small cell lung cancer patients: a population-based study
por: Zhao, Dechang, et al.
Publicado: (2023)

A tumor microenvironment gene set–Based prognostic signature for non-small-cell lung cancer
por: Wen, Yingsheng, et al.
Publicado: (2022)

Intrinsic Immunogenic Tumor Cell Death Subtypes Delineate Prognosis and Responsiveness to Immunotherapy in Lung Adenocarcinoma
por: He, Xiaotian, et al.
Publicado: (2023)

Resection of Early-Stage Second Primary Non-small Cell Lung Cancer After Small Cell Lung Cancer: A Population-Based Study
por: Zhang, Rusi, et al.
Publicado: (2020)

SERPINB5 is a prognostic biomarker and promotes proliferation, metastasis and epithelial‐mesenchymal transition (EMT) in lung adenocarcinoma
por: He, Xiaotian, et al.
Publicado: (2023)

Ten-year trends of the clinicopathological characteristics, surgical treatments and survival outcomes of operable lung cancer patients in monocenter: a retrospective cohort study
por: Zhao, Dechang, et al.
Publicado: (2023)

Combining Plasma miRNAs and Computed Tomography Features to Differentiate the Nature of Pulmonary Nodules
por: Xi, Kexing, et al.
Publicado: (2019)

Early Detection of Non-Small Cell Lung Cancer by Using a 12-microRNA Panel and a Nomogram for Assistant Diagnosis
por: Wang, Weidong, et al.
Publicado: (2020)

Impact of Different Types of Lymphadenectomy Combined With Different Extents of Tumor Resection on Survival Outcomes of Stage I Non-small-cell Lung Cancer: A Large-Cohort Real-World Study
por: Wang, Weidong, et al.
Publicado: (2019)

Development and validation of a preoperative noninvasive predictive model based on circular tumor DNA for lymph node metastasis in resectable non-small cell lung cancer
por: Zhang, Rusi, et al.
Publicado: (2020)

Ferroptosis-related lncRNAs signature to predict the survival and immune evasion for lung squamous cell carcinoma
por: Zhang, Rusi, et al.
Publicado: (2022)

Segmental resection is associated with decreased survival in patients with stage IA non-small cell lung cancer with a tumor size of 21–30 mm
por: Yu, Xiangyang, et al.
Publicado: (2021)

The value of preoperative Glasgow Prognostic Score and the C-Reactive Protein to Albumin Ratio as prognostic factors for long-term survival in pathological T1N0 esophageal squamous cell carcinoma
por: Yu, Xiangyang, et al.
Publicado: (2018)

Extent of resection and lymph node evaluation in early stage metachronous second primary lung cancer: a population-based study
por: Zhang, Rusi, et al.
Publicado: (2020)

Prognostic significance of combined preoperative platelet-to-lymphocyte ratio and lymphocyte-to-monocyte ratio in patients undergoing surgery with stage IB non-small-cell lung cancer
por: Chen, Yongqiang, et al.
Publicado: (2018)

First-generation EGFR tyrosine kinase inhibitor therapy in 106 patients with compound EGFR-mutated lung cancer: a single institution’s clinical practice experience
por: Yu, Xiangyang, et al.
Publicado: (2018)

Prognosis and distribution of lymph nodes metastases in resectable primary pulmonary lymphoepithelioma‐like carcinoma: A large cohort from a single center
por: Yu, Xiangyang, et al.
Publicado: (2018)

Intraoperative low-dose dopamine is associated with worse survival in patients with hepatocellular carcinoma: A propensity score matching analysis
por: Wang, Yan, et al.
Publicado: (2022)

A new method for accurately localizing and resecting pulmonary nodules
por: Wang, Gongming, et al.
Publicado: (2020)

An Immune-Related Signature Predicts Survival in Patients With Lung Adenocarcinoma
por: Zhang, Minghui, et al.
Publicado: (2019)

The Interferon Gamma-Related Long Noncoding RNA Signature Predicts Prognosis and Indicates Immune Microenvironment Infiltration in Colon Adenocarcinoma
por: Liu, Cong, et al.
Publicado: (2022)

Development and validation of web-based dynamic nomograms predictive of disease-free and overall survival in patients who underwent pneumonectomy for primary lung cancer
por: Yu, Xiangyang, et al.
Publicado: (2023)

A Combined Long Noncoding RNA Signature as a Candidate Prognostic Biomarker for Ovarian Cancer
por: Li, Hui, et al.
Publicado: (2021)

A Non-invasive Method to Diagnose Lung Adenocarcinoma
por: Yan, Mengmeng, et al.
Publicado: (2020)

The Ferroptosis-Related Noncoding RNA Signature as a Novel Prognostic Biomarker in the Tumor Microenvironment, Immunotherapy, and Drug Screening of Gastric Adenocarcinoma
por: Chen, Xinming, et al.
Publicado: (2021)

Radiomics Signature as a Predictive Factor for EGFR Mutations in Advanced Lung Adenocarcinoma
por: Hong, Duo, et al.
Publicado: (2020)

Corrigendum: A Non-invasive Method to Diagnose Lung Adenocarcinoma
por: Yan, Mengmeng, et al.
Publicado: (2020)

Pulmonary microbiota signatures adjacent to adenocarcinoma, squamous cell carcinoma and benign lesion
por: Li, Jinyou, et al.
Publicado: (2023)

Identification of an Individualized Metabolism Prognostic Signature and Related Therapy Regimens in Early Stage Lung Adenocarcinoma
por: Hu, Junjie, et al.
Publicado: (2021)

A Novel Pyroptosis-Related Gene Signature for Predicting the Prognosis and the Associated Immune Infiltration in Colon Adenocarcinoma
por: Chen, Zhiyuan, et al.
Publicado: (2022)

Immune-Stromal Score Signature: Novel Prognostic Tool of the Tumor Microenvironment in Lung Adenocarcinoma
por: Qi, Xiaoguang, et al.
Publicado: (2020)

A Prognostic Nomogram Combining Immune-Related Gene Signature and Clinical Factors Predicts Survival in Patients With Lung Adenocarcinoma
por: Song, Congkuan, et al.
Publicado: (2020)

Identification and Validation of Three Autophagy-Related Long Noncoding RNAs as Prognostic Signature in Cholangiocarcinoma
por: Liu, Ya Jun, et al.
Publicado: (2021)

Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients
por: Chen, Dongtai, et al.
Publicado: (2017)

Identification of an Immune-Related Signature for Predicting Prognosis in Patients With Pancreatic Ductal Adenocarcinoma
por: Wang, Weijia, et al.
Publicado: (2021)

A comparison of MASS-PCR and ARMS-PCR for the detection of lung cancer gene mutation
por: Cai, Ling, et al.
Publicado: (2019)

Glycosyltransferase-related long non-coding RNA signature predicts the prognosis of colon adenocarcinoma
por: Zhang, Jiawei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ucbdmugu3hrlkdr3na3ccmih5s